| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |